TSX/APTX (TSX/APTX)

Toronto Stock Exchange: TSX/APTX · CAD

CA$33.7

+0.89 (+2.7%)· Recorded snapshot

Market cap	7.7B
Revenue (ttm)	3.2B
Net income (ttm)	-27.3M
EPS (ttm)	-CA$0.16
Shares out	229M
P/E (forward)	16.1x
Dividend	CA$0.20 (0.59%)
Volume	189,574

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.2B
Net income (ttm): -27.3M
EPS (ttm): -CA$0.16
P/E (forward): 16.1x
Market cap: 7.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E16.1

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-11.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSX/APTX indicators

Market & fundamental data

Available fields

166

Groups with data

Currency

CAD

Showing 166 of 166 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Canada
Country code	CA
Earnings date	2026-11-12
Employees	6,000
Employees change	-216
Employees growth	-3.47%
Enterprise value	CAD 10.5B
Exchange	Toronto Stock Exchange
Financial currency	CAD
Financial report date	2026-06-30
First seen	2026-07-12
Fiscal year end	March
Founded	1974
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	CA03772D1015
Last earnings date	2026-08-12
Last refreshed	2026-10-29
Market cap	CAD 7.7B
Next earnings date	2026-11-12
Price	CAD 33.71
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	tsx/APTX
Website	https://www.apotex.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-0.49%
EV/EBIT	16.22x
EV/EBITDA	12.96x
EV/FCF	82.74x
EV/Sales	3.22x
FCF / EV yield	1.21%
FCF yield	1.65%
Forward P/E	16.12x
Industry forward P/E	34.38x
P/(OCF - SBC) ratio	65.55x
P/B ratio	21.47x
P/FCF ratio	60.5x
P/OCF ratio	28.51x
P/S ratio	2.35x
PEG ratio	0.65x
Price/EBITDA ratio	9.87x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	19.83%
EBITDA margin	23.83%
Effective tax rate	157.56%
FCF margin	3.89%
Gross margin	50.69%
Operating margin	19.83%
Pretax margin	1.48%
Profit margin	-0.85%
Profit per employee	CAD -4,545
Revenue per employee	CAD 532,754
ROCE	18.31%
ROIC	-11.75%
SBC / revenue	4.66%
Tax / revenue	2.34%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
OCF growth (QoQ)	-92.79%
Revenue growth	4.22%
Revenue growth (Q)	-25.77%
Revenue growth (QoQ)	-25.76%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -139.4M
Depreciation and amortization	CAD 127.8M
EBIT	CAD 633.8M
EBITDA	CAD 761.6M
EPS	CAD -0.16
FCF per share	CAD 0.54
Financing cash flow	CAD -197M
Free cash flow	CAD 124.3M
Free cash flow minus SBC	CAD -24.7M
Gross profit	CAD 1.6B
Income taxes	CAD 74.6M
Investing cash flow	CAD -204.5M
Net borrowing	CAD 320M
Net cash flow	CAD -131.3M
Net income	CAD -27.3M
Operating cash flow minus SBC	CAD 114.7M
Operating income	CAD 633.8M
Revenue	CAD 3.2B
Stock-based compensation	CAD 149M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.97
Book value per share	CAD 1.53
Debt / EBITDA	3.81
Debt / equity	8.63
Debt / FCF	24.33
Goodwill	CAD 296.3M
Interest coverage	2.41
Long-term assets	CAD 2.4B
Long-term liabilities	CAD 3.1B
Net cash (debt)	CAD -2.8B
Net cash / market cap	-36.77%
Net debt / EBITDA	3.63
Net debt / equity	7.89
Net debt / FCF	22.24
Piotroski F-Score	2
Property, plant and equipment	CAD 1.1B
Shareholders' equity	CAD 350.2M
Tangible book value	CAD -701.6M
Tangible book value per share	CAD -3.07
Total assets	CAD 4.9B
Total cash	CAD 258.8M
Total debt	CAD 3B
Total liabilities	CAD 4.5B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	CAD 2.5B
Current liabilities	CAD 1.4B
Current ratio	1.77
Net working capital	CAD 928.9M
Quick ratio	0.94
Working capital	CAD 1.1B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-09-30
Dividend payment years	1
Dividend per share	CAD 0.20
Dividend yield	0.59%
Ex-dividend date	2026-09-15
FCF payout ratio	11.06%
Last dividend	CAD 0.06
Shareholder yield	0.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1D price change	2.71%
1M price change	4.92%
1M total return	4.92%
1W price change	1.35%
1W total return	1.35%
20-day SMA	CAD 31.86
3M price change	-5.31%
3M total return	-5.16%
50-day SMA	CAD 32.68
52-week high	CAD 40.18
52-week high date	2026-07-16
52-week low	CAD 26.05
52-week low date	2026-06-10
All-time high	CAD 40.18
All-time high date	2026-07-16
All-time low	CAD 26.05
All-time low date	2026-06-10
Average true range (ATR)	CAD 0.97
Average volume	300.3K
Beta (1Y)	-0.32
Change from 52-week high	-16.1%
Change from 52-week low	29.41%
Change from all-time high	-16.18%
Change from all-time low	29.29%
Change from open	1.84%
Day's gap	0.85%
Dollar volume	CAD 6.4M
High price	CAD 33.92
Low price	CAD 32.85
Monthly RSI	0
Open price	CAD 33.10
Position in 52-week range	80.37%
Previous close	CAD 32.82
Price vs 20-day SMA	5.71%
Price vs 50-day SMA	3.07%
Relative volume	0.63
RSI	59.19
Sharpe ratio	1.43
Sortino ratio	2.28
Volume	189.6K
Weekly RSI	54.86

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	228.7M
Shares change (QoQ)	4.22%
Shares held by insiders	0.14%
Shares held by institutions	10.32%
Shares outstanding	229M

Deeper analysis on TSX/APTX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/APTX report

Is a complete TSX/APTX research report available?

No complete published report is available for tsx/APTX (TSX/APTX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/APTX (TSX/APTX)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/APTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/APTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/APTX

Frequently asked questions